| Full version of the proceedings Webinar information | |||||||||
| ●Editorial | Kurihara C, Saio T， Imamura K，Greco D |
4-7 | Full text | ||||||
| ●COVID-19 and bioethics Part 3: Pandemic and research ethics－Democracy, placebo and post-trial access Co-organized by the COVID-19 Task Force, Japan Association for Bioethics and the Brazilian Society of Bioethics |
9-109 | Abstract | |||||||
| Agenda and participants | 11-3 | Agenda | |||||||
| ［Electronic publications only］------------------------------------------------------------------------------------------------------ | |||||||||
| ・Day 1 | |||||||||
| Opening Remarks of the Day 1 session | Saio T，Greco D，Imamura K | 14-5 | |||||||
| Opening remarks and situation in Japan and the world: Proposal on ethics of placebo-controlled trials and post-trial access in the Declaration of Helsinki | Kurihara C，Saio T， Matsuyama K，Imamura K | 16-23 | |||||||
| Ethics in vaccine research: The COVID-19 pandemic | Macklin R | 24-9 | |||||||
| Revisiting the debate over placebo use in developing countries in the age of COVID-19 | Lurie P | 30-41 | |||||||
| Discussion (Day 1 No. 1) | 42-4 | ||||||||
| From Nuremberg to Helsinki: Historicising research ethics during health crisis | Schmidt U | 45-50 | |||||||
| Discussion (Day 1 No. 2) | 51-60 | ||||||||
| ・Day 2 | |||||||||
| Opening Remarks of the Day 2 session | Saio T，Greco D，Imamura K | 61-2 | |||||||
| Ethics in vaccine allocation in developing countries | Dhai A | 63-71 | |||||||
| Médecins Sans Frontières (MSF) Access Campaign for equitable access in the world | Aloudat T | 72-7 | |||||||
| Discussion (Day 2 No. 1) | 78-81 | ||||||||
| Post-Trial Access for All: Perspective of achieving universal access to adequate public health | Greco D | 82-93 | |||||||
| Learnings for ethics from Covid-19 | Crawley FP | 94-102 | |||||||
| Discussion (Day 2 No. 2) | 103-9 | ||||||||
| -------------------------------------------------------------------------------------------------------------------------------------------- | |||||||||
| ●Japanese translation of a short report in IFAPP Today | |||||||||
| Link to the original newsletter: COVID-19 and bioethics Part 3: Pandemic and research ethics－Democracy, placebo and post-trial access | Kurihara C | 213-6 | Full text | ||||||
| ●Forum | |||||||||
| A group of Patient Public Involvement (PPI) shared their feelings after reading “DECLARATION OF HELSINKI”: Part 3 Graphic Recording of the discussion on placebo-controlled trial and post-trial access | Yoshikawa K，Inoue K， Kai H，et al． |
217-26 | Full text | ||||||